| Literature DB >> 19572874 |
Pierre-Francois Winum1, Guillaume Cayla, Madeleine Rubini, Lionel Beck, Patrick Messner-Pellenc.
Abstract
We present the case of a 67-year-old woman with cardiomyopathy induced by inappropriate sinus tachycardia (IST) and a particularly high average heart rate. The patient was resistant and/or intolerant to treatment with conventional rate-slowing medications. We used ivabradine--a specific sinus node I(f) current inhibitor--and successfully lowered the heart rate (33 beats per minute mean heart rate decrease). Symptoms, systolic function, and heart rate variability parameters recovered dramatically. No side effect was noted. We suggest that ivabradine--evaluated in trials to treat stable angina--should be considered as a second-line treatment in patients with very symptomatic and refractory IST.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19572874 DOI: 10.1111/j.1540-8159.2009.02414.x
Source DB: PubMed Journal: Pacing Clin Electrophysiol ISSN: 0147-8389 Impact factor: 1.976